Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-6-12
|
pubmed:abstractText |
The effect of probenecid on the outward transport of fluorescein from vitreous to blood was studied in 13 insulin-dependent diabetic patients with background retinopathy in a randomised double-masked placebo controlled cross-over study. Fluorescein and fluorescein glucuronide was separated in the vitreous and in plasma by differential spectrofluorometry. The data for fluorescein were analysed using a simplified mathematical model of the eye. The inward permeability was estimated from data obtained 1 h after injection and the outward transport from data obtained 7 h after injection. During placebo treatment the mean inward permeability was 3.75 x 10(-7) cm/sec and the mean outward permeability was 2.25 x 10(-5) cm/sec. During probenecid treatment the mean inward permeability was 3.34 x 10(-7) cm/sec and the mean outward permeability was 1.44 x 10(-5) cm/sec. Thus, we found no significant change in inward permeability (p = 0.5879), whereas a significant decrease of 36% was found in the outward permeability of fluorescein (p = 0.0171). The demonstration that the outward permeability, which is more than 100-fold higher than the inward permeability in the healthy eye, is significantly decreased by probenecid, demonstrates that active transport is involved in movement of fluorescein across the blood-retina barrier from the vitreous to the plasma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0001-639X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
663-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7747571-Adult,
pubmed-meshheading:7747571-Biological Transport, Active,
pubmed-meshheading:7747571-Blood,
pubmed-meshheading:7747571-Blood-Retinal Barrier,
pubmed-meshheading:7747571-Capillary Permeability,
pubmed-meshheading:7747571-Cross-Over Studies,
pubmed-meshheading:7747571-Diabetes Mellitus, Type 1,
pubmed-meshheading:7747571-Diabetic Retinopathy,
pubmed-meshheading:7747571-Double-Blind Method,
pubmed-meshheading:7747571-Fluorescein,
pubmed-meshheading:7747571-Fluoresceins,
pubmed-meshheading:7747571-Humans,
pubmed-meshheading:7747571-Male,
pubmed-meshheading:7747571-Middle Aged,
pubmed-meshheading:7747571-Probenecid,
pubmed-meshheading:7747571-Vitreous Body
|
pubmed:year |
1994
|
pubmed:articleTitle |
Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
|
pubmed:affiliation |
Department of Ophthalmology, Gentofte Hospital, University of Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|